OnabotulinumtoxinA

Details

Files

Generic Name:

OnabotulinumtoxinA

Project Status:

Complete

Therapeutic Area:

Neurogenic detrusor overactivity

Manufacturer:

Allergan Inc.

Call for patient/clinician input open:

January 23, 2012

Brand Name:

Botox

Project Line:

Reimbursement Review

Project Number:

SR0268-000

Call for patient/clinician input closed:

February 17, 2012

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Neurogenic Detrusor Overactivity

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

July 19, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : January 31, 2012